Tyropanoic acid

Tyropanoic acid
Names
	Preferred IUPAC name 2-[(3-Butanamido-2,4,6-triiodophenyl)methyl]butanoic acid
	Other names 2-(3-Butyramido-2,4,6-triiodobenzyl)butanoic acid; 2-[[2,4,6-Triiodo-3-(1-oxobutylamino)phenyl]methyl]butanoic acid
Identifiers
CAS Number	27293-82-9 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL1201261 ;
ChemSpider	5409 ;
ECHA InfoCard	100.043.976
EC Number	248-389-8;
KEGG	D01884 ;
MeSH	D014441
PubChem CID	5611;
UNII	4F05V145YR ;
CompTox Dashboard (EPA)	DTXSID5048269 ;
	InChI InChI=1S/C15H18I3NO3/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22/h7-8H,3-6H2,1-2H3,(H,19,20)(H,21,22) Key: YMOXVLQZFAUUKI-UHFFFAOYSA-N ;
	SMILES CCCC(=O)NC1=C(C=C(C(=C1I)CC(CC)C(=O)O)I)I;
Properties
Chemical formula	C15H18I3NO3
Molar mass	641.02 g/mol
Pharmacology
ATC code	V08AC09 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

Tyropanoic acid and its salt sodium tyropanoate are radiocontrast agents used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.[1] The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.[2]

References

"PubChem CID 5611".
Felicetta, James V.; Green, William L.; Nelp, Wil B. (May 1980). "Inhibition of hepatic binding of thyroxine by cholecystographic agents". J. Clin. Invest. 65 (5): 1032–40. doi:10.1172/JCI109755. PMC 371433. PMID 7364937.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "PubChem CID 5611".

[2] Felicetta, James V.; Green, William L.; Nelp, Wil B. (May 1980). "Inhibition of hepatic binding of thyroxine by cholecystographic agents". J. Clin. Invest. 65 (5): 1032–40. doi:10.1172/JCI109755. PMC 371433. PMID 7364937.